Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Research evaluating the impact of continuous positive airway pressure (CPAP) & walking exercise on fatigue severity, liver enzymes and sleeping quality in patients with non-alcoholic fatty liver disease who also have obstructive sleep apnea. Forty patients are divided into two groups: twenty patients CPAP and other twenty patients for CPAP and walking program .
Research evaluating the impact of continuous positive airway pressure (CPAP) & walking exercise on fatigue severity, liver enzymes and sleeping quality in patients with non-alcoholic fatty liver disease who also have obstructive sleep apnea. Forty patients are divided into two groups: twenty patients CPAP and other twenty patients for CPAP and walking program .
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| continuous positive airway pressure therapy | Active Comparator | The continuous positive airway pressure therapy equipment is used for 12 weeks, all patients in this group groups must utilize the CPAP machine for 4 hours each night. |
|
| Free walking & continuous positive airway pressure therapy | Experimental | Each patient is required to walk 30 minutes, seven days a week for 12 weeks. & The continuous positive airway pressure therapy equipment is used for 12 weeks, all patients in both groups must utilize the CPAP machine for 4 hours each night. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| continuous positive airway pressure | Behavioral | continuous positive airway pressure therapy for a period of 12 weeks, all patients with in this group are required to utilize the CPAP machine for at least 4 hours each night |
| Measure | Description | Time Frame |
|---|---|---|
| Alanine tranaminase | serum hepatic enzyme | it will be measured after 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Asparatate transamianse | serum hepatic enzyme | it will be measured after 12 weeks |
| Body mass index | it will be masusured on empty stomach and bladder |
Not provided
Inclusion Criteria:
Exclusion Criteria:
self-representation of gender identity.
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| El-Hadidy Hagar, PHD | Contact | 00201007453552 | hagarhadidy2016@gmail.com | |
| El-gohary Ola, PHD | Contact | 01227191398 |
| Name | Affiliation | Role |
|---|---|---|
| El-Hadidy Hagar | Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ahram canadian university | Recruiting | Giza | Egypt |
Not provided
| ID | Term |
|---|---|
| D020181 | Sleep Apnea, Obstructive |
| D065626 | Non-alcoholic Fatty Liver Disease |
| ID | Term |
|---|---|
| D012891 | Sleep Apnea Syndromes |
| D001049 | Apnea |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D045422 | Continuous Positive Airway Pressure |
| ID | Term |
|---|---|
| D011175 | Positive-Pressure Respiration |
| D012121 | Respiration, Artificial |
| D058109 | Airway Management |
| D013812 | Therapeutics |
Not provided
Not provided
Forty patients suffering from obstructive sleep apnea are divided into two groups: one for CPAP and the other for CPAP and free walking program.
Not provided
Not provided
The authors of this clinical trial and patients do not provide the study outcome examiners with information regarding device therapy or free walking exercise.
| free walking exercise and continuous positive airway pressure | Behavioral | patients will receive continuous positive airway pressure therapy for a period of 12 weeks, all patients with in this group are required to utilize the CPAP machine for at least 4 hours each night. Also, patients will perform walking exercise for 30 mint, daily for 12 weeks |
|
| it will be measured after 12 weeks |
| triglycerodes | it will be meausred in plasma | it will be assessed after 12 weeks |
| Pittsiburg sleeping quality index | a questionnaire that wil be used for assessing sleeping quality | it will be assessed after 12 weeks |
| fatigue severity scale | a questionnaire that wil be used for assessing fatigue | it will be assessed after 12 weeks |
| Epworth sleepness scale | a questionnaire that wil be used for daytime sleepness | it will be assessed after 12 weeks |
| D020919 |
| Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D009422 | Nervous System Diseases |
| D005234 | Fatty Liver |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
| D012138 |
| Respiratory Therapy |